Use of low molecular weight heparin and hemoglobin fall in COVID-19 patients: A STROBE-compliant study

In patients with coronavirus disease 2019 (COVID-19), anticoagulation was suggested as a mitigating strategy. However, little research has been conducted on the adverse consequences of anticoagulant medication. This study aimed to investigate the adverse effect of low molecular weight heparin (LMWH)...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Ping-Yang, Huang, Mao-Hong, Hu, An-Ke, Lai, Yan-Ting, Zeng, Hui-Qing, Zhang, Xiao-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477703/
https://www.ncbi.nlm.nih.gov/pubmed/36123921
http://dx.doi.org/10.1097/MD.0000000000030367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477703/
https://www.ncbi.nlm.nih.gov/pubmed/36123921
http://dx.doi.org/10.1097/MD.0000000000030367

Ejemplares similares